Since its introduction in 2013, the use of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) 9 system for genome editing has exploded. Products for CRISPR/Cas9 range from plasmids and oligonucleotides to transgenic animals and screening services. According to Bioinformatics LLC’s report, “The Market for CRISPR/Cas9 Genome Editing Products,” published in May and based […]
Company Announcements SYGNIS named several distributors: D-Mark Biosciences distributes the TruePrime Single Cell WGA Kit in North America, Cambridge Bioscience distributes TruePrime products in the UK and Ireland, Welgene Biotech distributes the product portfolio in Taiwan, and Biotop distributes the product portfolio in Finland. In March, LGC announced a strategic cooperation agreement with Hua-zhi Rice […]
Tucson, AZ 5/6/15; Washington, DC 5/6/15—HTG Molecular Diagnostics, a provider of technology for complex molecular profiling, has completed an IPO. The company listed its shares on the NASDAQ Global Market, offering 3,570,000 shares at a price of $14 per share for estimated net proceeds of $44.4 million, or $51.4 million if the underwriters’ overallotment option […]
The annual American Association of Cancer Research meeting (AACR) was held April 18–22 in Philadelphia, Pennsylvania. Attendance for the conference was 19,300, up about 4% from last year (see IBO 4/30/14). The number of companies exhibiting totaled 438. A notable trend in the exhibit hall was the number of CRISPR/Cas9 products and services available from […]
Company Announcements Cepheid 2014 Non-Clinical revenue declined 29.9% to $29.0 million, or 6% of total revenues, primarily due to lower sales of anthrax test cartridges. North America accounted for 86% of Non-Clinical sales. Non-Clinical revenue is expected to decline again this year. WaferGen Bio-systems entered into a research collaboration with the Familial Breast Cancer Research […]
Washington, DC 2/27/15; Billerica, MA 3/2/15—RainDance Technologies has filed with the SEC for a proposed IPO of its common stock on the NASDAQ Stock Market under the symbol “RAIN.” The company develops, manufactures and sells systems based on its digital droplet technology as well as consumables and assays for the detection and analysis of complex […]
Company Announcements Eppendorf licensed patents covering gradient technology for thermal cyclers to SensoQuest in September 2014. Rubicon Genomics named new distributors in October 2014: CliniSciences for France, Spain and North Africa; Nerliens Meszansky for Norway; Shanghai Nanodigmnio Biotechnology for China; and GeneLabs Life Science for Taiwan. Rubicon Genomics 2014 sales grew 28%. RainDance Technologies named […]
Company Announcements RUCDR Infinite Biologics was named a RainDance Center of Excellence in June. Thermo Fisher Scientific in July signed an exclusive agreement with NewLab Engineering, a subsidiary of COPAN Italia, to distribute Card Processing Automation technology for preparing DNA samples for human identification in forensic, paternity and research labs. Under an OEM agreement with […]
IVD relies on a number of technologies to test for certain conditions, diseases and infections. Molecular diagnostic (MDx) tests use genomic and proteomic technologies for such analyses. The February 2014 Strategic Directions International report, “The Coveted Molecular Diagnostics Market: From Clinical Research to Diagnosis and Personalized Medicine—Innovative Technologies Break Through,” covers the use of nucleic […]
Biologic drugs continue to be one of the fastest-growing categories of the pharmaceutical market. US sales of biologics grew 9.7% annually from 2010 to 2012 to $65.5 billion, or 47% of the global market, according to EvaluatePharma. According to the Pharmaceutical Research and Manufacturers of America, 907 biologic medicines and vaccines are in development at […]
Pay Invoice
Latest Blogs
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
